ROQUETTE: A GLOBAL SUPPLIER FOR GLOBAL NEEDS

Article

Roquette is a long-established supplier of actives and excipients, associated to many services, to the pharmaceutical and cosmetics industries. Whatever your requirements and aims, discover Roquette Pharma's Solutions.

ROQUETTE: A GLOBAL SUPPLIER FOR GLOBAL NEEDS

To meet customers’ needs, a wide range of excipients and actives are available in Roquette’s portofolio, notably in the areas of:

  • Injectables (enteral and parenteral nutrition)
  • Tablets obtained by direct compression or wet granulation
  • Film forming and film coating
  • Syrups, suspensions, Granules and sachets
  • Orodispersible tablets
  • OTC and nutraceuticals
  • Toothpastes and mouthwashes
  • Encapsulation

As solution provider, new associated services are also proposed:

Roquette now offers on-site assistance for LYCOAT®, film coating polymer, and ReadiLYCOAT® , ready-to-use coating systems. LYCOAT® has proven to be exceptionally inert, unlike other coating polymers. To obtain more process insights: www.readilycoat.com.

Today, the direct scale-up of formulations offers a new way to reduce drug development time and cost. To further strengthen this drive, Roquette and the Institut de la Garonne have pooled their expertise to provide a new compression modeling service.

To be as close as possible to your demand, Roquette is constantly strengthening its worldwide presence. You can find your local contact on our website.

At Roquette we help you formulate whatever you want, whenever you want, wherever you want.

Company name: ROQUETTE
Website: www.roquettepharma.com
E-mail: pharma.business.unit@roquette.com

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Related Content